LU71427A1 - - Google Patents
Info
- Publication number
- LU71427A1 LU71427A1 LU71427A LU71427A LU71427A1 LU 71427 A1 LU71427 A1 LU 71427A1 LU 71427 A LU71427 A LU 71427A LU 71427 A LU71427 A LU 71427A LU 71427 A1 LU71427 A1 LU 71427A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/421,992 US3935213A (en) | 1973-12-05 | 1973-12-05 | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU71427A1 true LU71427A1 (en:Method) | 1975-08-20 |
Family
ID=23672938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU71427A LU71427A1 (en:Method) | 1973-12-05 | 1974-12-05 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US3935213A (en:Method) |
| JP (1) | JPS5093987A (en:Method) |
| AR (1) | AR207766A1 (en:Method) |
| AT (1) | AT342598B (en:Method) |
| BE (1) | BE822873A (en:Method) |
| CA (1) | CA1010866A (en:Method) |
| CH (1) | CH587843A5 (en:Method) |
| CS (1) | CS189678B2 (en:Method) |
| DD (1) | DD114950A5 (en:Method) |
| DE (1) | DE2457911A1 (en:Method) |
| DK (1) | DK135376B (en:Method) |
| EG (1) | EG11404A (en:Method) |
| ES (1) | ES432483A1 (en:Method) |
| FI (1) | FI59799B (en:Method) |
| FR (1) | FR2253750B1 (en:Method) |
| GB (1) | GB1464583A (en:Method) |
| HK (1) | HK28379A (en:Method) |
| IE (1) | IE40204B1 (en:Method) |
| IL (1) | IL46102A (en:Method) |
| IN (1) | IN140460B (en:Method) |
| KE (1) | KE2933A (en:Method) |
| LU (1) | LU71427A1 (en:Method) |
| MY (1) | MY7900247A (en:Method) |
| NL (1) | NL7415793A (en:Method) |
| NO (1) | NO141898C (en:Method) |
| PH (1) | PH10594A (en:Method) |
| PL (1) | PL94120B1 (en:Method) |
| RO (1) | RO65957A (en:Method) |
| SE (1) | SE411348B (en:Method) |
| SU (1) | SU563914A3 (en:Method) |
| YU (1) | YU36948B (en:Method) |
| ZA (1) | ZA747593B (en:Method) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001237A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | Oxazole, isoxazole, thiazole and isothiazole amides |
| US4001238A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | 1,3,4-oxadiazole amides |
| US4060615A (en) * | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
| SE435380B (sv) | 1976-06-15 | 1984-09-24 | Pfizer | Forfarande for framstellning av kinazolinforeningar |
| US4062844A (en) * | 1976-09-20 | 1977-12-13 | Pfizer Inc. | Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines |
| FI58125C (fi) * | 1976-12-15 | 1985-01-02 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan |
| FI58124C (fi) * | 1976-12-15 | 1980-12-10 | Orion Yhtymae Oy | Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan |
| US4138561A (en) * | 1977-09-30 | 1979-02-06 | Bristol-Myers Company | Cyanocarboxamidines and quinazoline process |
| IN151190B (en:Method) * | 1978-05-18 | 1983-03-05 | Pfizer | |
| FI67699C (fi) * | 1979-01-31 | 1985-05-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan |
| US4426382A (en) | 1980-02-13 | 1984-01-17 | Sankyo Company Limited | 4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use |
| US4351832A (en) * | 1980-04-18 | 1982-09-28 | American Home Products Corporation | 2-(Piperazinyl)-4-pyrimidinamines |
| US4333937A (en) * | 1980-04-18 | 1982-06-08 | American Home Products Corp. | 2-(Piperazinyl)-4-pyrimioinamines |
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| FI79107C (fi) * | 1984-06-25 | 1989-11-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. |
| CA2077252C (en) * | 1992-08-31 | 2001-04-10 | Khashayar Karimian | Methods of making ureas and guanidines, and intermediates therefor |
| EP0794178A4 (en) * | 1994-11-25 | 1998-02-25 | Nippon Chemiphar Co | CHINAZOLIN DERIVATIVES |
| US6313294B1 (en) | 1998-02-04 | 2001-11-06 | Development Center For Biotechnology | Process for preparing amides |
| US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
| US20070087061A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
-
1973
- 1973-12-05 US US05/421,992 patent/US3935213A/en not_active Expired - Lifetime
-
1974
- 1974-01-01 AR AR256788A patent/AR207766A1/es active
- 1974-11-06 SE SE7413960A patent/SE411348B/xx not_active IP Right Cessation
- 1974-11-12 IE IE2320/74A patent/IE40204B1/xx unknown
- 1974-11-19 IN IN2559/CAL/74A patent/IN140460B/en unknown
- 1974-11-21 IL IL46102A patent/IL46102A/en unknown
- 1974-11-25 PH PH16558A patent/PH10594A/en unknown
- 1974-11-25 CA CA214,493A patent/CA1010866A/en not_active Expired
- 1974-11-28 YU YU3178/74A patent/YU36948B/xx unknown
- 1974-11-28 ZA ZA00747593A patent/ZA747593B/xx unknown
- 1974-11-30 ES ES432483A patent/ES432483A1/es not_active Expired
- 1974-12-03 BE BE151086A patent/BE822873A/xx not_active IP Right Cessation
- 1974-12-03 RO RO7480674A patent/RO65957A/ro unknown
- 1974-12-04 DE DE19742457911 patent/DE2457911A1/de not_active Ceased
- 1974-12-04 NO NO744382A patent/NO141898C/no unknown
- 1974-12-04 DK DK629874AA patent/DK135376B/da unknown
- 1974-12-04 SU SU7402080926A patent/SU563914A3/ru active
- 1974-12-04 EG EG534/74A patent/EG11404A/xx active
- 1974-12-04 GB GB5252774A patent/GB1464583A/en not_active Expired
- 1974-12-04 AT AT970274A patent/AT342598B/de not_active IP Right Cessation
- 1974-12-04 NL NL7415793A patent/NL7415793A/xx not_active Application Discontinuation
- 1974-12-04 DD DD182787A patent/DD114950A5/xx unknown
- 1974-12-04 FI FI3514/74A patent/FI59799B/fi active
- 1974-12-05 JP JP49140046A patent/JPS5093987A/ja active Pending
- 1974-12-05 CH CH1616374A patent/CH587843A5/xx not_active IP Right Cessation
- 1974-12-05 CS CS748318A patent/CS189678B2/cs unknown
- 1974-12-05 LU LU71427A patent/LU71427A1/xx unknown
- 1974-12-05 FR FR7439785A patent/FR2253750B1/fr not_active Expired
- 1974-12-05 PL PL1974176207A patent/PL94120B1/pl unknown
-
1979
- 1979-03-15 KE KE2933A patent/KE2933A/xx unknown
- 1979-05-03 HK HK283/79A patent/HK28379A/xx unknown
- 1979-12-30 MY MY247/79A patent/MY7900247A/xx unknown